期刊文献+

冠心病患者血清miRNA表达与糖代谢异常的相关性分析 被引量:1

Correlation analysis of abnormal glucose metabolism and serum miRNA expression in patients with coronary heart disease
下载PDF
导出
摘要 目的探讨冠心病患者血清mi RNA表达与糖代谢异常的相关性。方法选取我院心内科收治的45例患者为研究对象,分为对照组、冠心病组和合并组(糖尿病并冠心病),各15例。采用实时定量PCR技术对不同分组患者血清中mi R-126及mi R-146进行检测,比较三组患者的mi R-126及mi R-146表达水平。结果冠心病组及合并组患者较对照组mi R-126在体内的表达水平明显较高(P<0.05),mi R-146表达水平三组比较差异无统计学意义(P>0.05)。结论冠心病患者血清mi RNA表达水平与糖代谢异常的存在一定的相关性,血清mi RNA检测可在临床中作为指导糖尿病大血管病变诊断的参考依据。 Objective To study the correlation of the abnormal glucose metabolism and serum miRNA expression in patients with coronary heart disease. Methods Forty-five patients admitted in cardiovascular department in our hospital were divided into control group, coronary heart disease group and combination group(diabetes mellitus and coronary heart disease), with 15 cases in each group. The expression levels of the serum mi R-126 and miR-146 of the three groups were detected by real-time quantitative PCR technique. The expression levels of the serum mi R-126 and miR-146 of the three groups were compared.Results The expression levels of the serum miR-126 of the coronary heart disease group and combination group were higher than those of the control group(P〈0.05). There were no significant difference in the expression levels of the serum miR-146 of three groups(P〉0.05). Conclusion There is certain correlation of the abnormal glucose metabolism and serum miRNA in patients with coronary heart disease. It can be used as a reference for the diagnosis of diabetic macrovascular disease in clinic.
作者 秦凤 张惠莉
出处 《临床医学研究与实践》 2017年第6期36-37,共2页 Clinical Research and Practice
关键词 冠心病 微RNAS 基因表达 coronary disease miRNA gene expression
  • 相关文献

参考文献4

二级参考文献37

  • 1刘燕荣,陈君柱,王兴祥,朱军慧,谢旭东,孙坚.冠心病患者外周血内皮祖细胞的数量和功能变化[J].浙江大学学报(医学版),2005,34(2):163-166. 被引量:5
  • 2潘长玉,金文胜.2型糖尿病流行病学[J].中华内分泌代谢杂志,2005,21(5). 被引量:168
  • 3无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2052
  • 4柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2125
  • 5Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol, 1993,22(4) : 6A-13A.
  • 6Kannel WB, Hjorthnd M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol, 1974, 34( 1 ) :29-34.
  • 7Swan JW, Walton C, Godsland IF, et al. Insulin resistance in chronic heart failure. Eur Heart J, 1994, 15(11) : 1528-1532.
  • 8Tenenbaum A, Motro M, Fisman EZ, et al. Functional class in patients with heart failure is associated with the development of diabetes. Am J Med, 2003, 114(4) :271-275.
  • 9Clinical outcome with enalapfil in symptomatic chronic heart failure: a dose comparison. The NETWORK investigators. Eur Heart J, 1998, 19 (3):481-489.
  • 10Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med, 1991,325 (5) :303- 310.

共引文献52

同被引文献11

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部